preclinics

Executive Summary

preclinics GmbH is a German contract research organization (CRO) offering integrated preclinical services for drug and medical device development. Specializing in pharmacokinetics, efficacy testing, and antibody discovery (including camelid VHH), the company also supplies biological products and custom research instruments. Operating from multiple sites in Germany and Italy, preclinics combines molecular biology, in vivo testing, and instrument fabrication to accelerate early-stage R&D for biopharma and medtech clients. As a private CRO with a 2017 founding, it addresses growing outsourcing demand in preclinical development, particularly for complex biologics. Its capabilities in VHH antibody development and custom instrument design provide differentiation in the competitive CRO market.

Upcoming Catalysts (preview)

• Q3 2026Major contract with large pharma for VHH antibody discovery65% success
• Q2 2026Expansion of Munich lab facility to double in vivo capacity80% success
• Q1 2027ISO 13485 certification for medical device testing services70% success